Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Diseases

Explore clinical trials studying Uterine Cervical Diseases. Study availability and eligibility vary by location and protocol.

1,783 public trials 378 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Diseases trial results

Recruiting

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

NCT05758688

Conditions
Cervical Cancer, Endometrial Cancer, Endometrial Neoplasms, +14 more
Locations
  • Virtua Health Voorhees Township, New Jersey, United States
  • Lancaster General Health - Ann B. Barshinger Cancer Institute Lancaster, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

NCT04865887

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • John Theurer Cancer Center at Hackensack UMC Hackensack, New Jersey, United States
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details

Related conditions